Maternal hybrid immunity and risk of infant COVID-19 hospitalizations: national case-control study in Israel

Maternal hybrid immunity and risk of infant COVID-19 hospitalizations: national case-control study in Israel

Abstract Hybrid immunity, acquired through vaccination followed or preceded by a COVID-19 infection, elicits robust antibody augmentation. We hypothesize that maternal hybrid immunity will provide greater infant protection than other forms of COVID-19 immunity in the first 6 months of life. We condu...

Full description

Bibliographic Details
Main Authors: Joshua Guedalia, Michal Lipschuetz, Adva Cahen-Peretz, Sarah M. Cohen, Yishai Sompolinsky, Galit Shefer, Eli Melul, Zivanit Ergaz-Shaltiel, Debra Goldman-Wohl, Simcha Yagel, Ronit Calderon-Margalit, Ofer Beharier
Format: Article
Language:English
Published: Nature Portfolio 2024-04-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-024-46694-x

Internet

https://doi.org/10.1038/s41467-024-46694-x

Similar Items